Annual EBITDA
$53.20 M
-$69.70 M-56.71%
31 December 2023
Summary:
Avanos Medical annual earnings before interest, taxes, depreciation & amortization is currently $53.20 million, with the most recent change of -$69.70 million (-56.71%) on 31 December 2023. During the last 3 years, it has risen by +$55.20 million (+2760.00%). AVNS annual EBITDA is now -82.09% below its all-time high of $297.10 million, reached on 31 December 2013.AVNS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$24.40 M
+$3.80 M+18.45%
30 September 2024
Summary:
Avanos Medical quarterly earnings before interest, taxes, depreciation & amortization is currently $24.40 million, with the most recent change of +$3.80 million (+18.45%) on 30 September 2024. Over the past year, it has increased by +$11.30 million (+86.26%). AVNS quarterly EBITDA is now -91.27% below its all-time high of $279.40 million, reached on 31 December 2015.AVNS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$84.70 M
+$11.30 M+15.40%
30 September 2024
Summary:
Avanos Medical TTM earnings before interest, taxes, depreciation & amortization is currently $84.70 million, with the most recent change of +$11.30 million (+15.40%) on 30 September 2024. Over the past year, it has increased by +$24.50 million (+40.70%). AVNS TTM EBITDA is now -78.82% below its all-time high of $399.90 million, reached on 30 September 2016.AVNS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVNS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.7% | +86.3% | +40.7% |
| 3 y3 years | +2760.0% | +84.8% | +499.5% |
| 5 y5 years | +27.3% | +401.2% | +568.0% |
AVNS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -56.7% | +2760.0% | -20.5% | +289.1% | -12.7% | +499.5% |
| 5 y | 5 years | -56.7% | +539.7% | -20.5% | +172.0% | -12.7% | +458.9% |
| alltime | all time | -82.1% | +176.0% | -91.3% | +105.5% | -78.8% | +128.1% |
Avanos Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.40 M(+18.4%) | $84.70 M(+15.4%) |
| June 2024 | - | $20.60 M(+28.7%) | $73.40 M(+17.1%) |
| Mar 2024 | - | $16.00 M(-32.5%) | $62.70 M(+17.9%) |
| Dec 2023 | $53.20 M(-56.7%) | $23.70 M(+80.9%) | $53.20 M(-11.6%) |
| Sept 2023 | - | $13.10 M(+32.3%) | $60.20 M(-16.2%) |
| June 2023 | - | $9.90 M(+52.3%) | $71.80 M(-14.3%) |
| Mar 2023 | - | $6.50 M(-78.8%) | $83.80 M(-13.6%) |
| Dec 2022 | $122.90 M(+151.3%) | $30.70 M(+24.3%) | $97.00 M(+81.6%) |
| Sept 2022 | - | $24.70 M(+12.8%) | $53.40 M(+27.4%) |
| June 2022 | - | $21.90 M(+11.2%) | $41.90 M(+88.7%) |
| Mar 2022 | - | $19.70 M(-252.7%) | $22.20 M(<-9900.0%) |
| Dec 2021 | $48.90 M(-2545.0%) | -$12.90 M(-197.7%) | -$200.00 K(-99.1%) |
| Sept 2021 | - | $13.20 M(+500.0%) | -$21.20 M(-10.2%) |
| June 2021 | - | $2.20 M(-181.5%) | -$23.60 M(+42.2%) |
| Mar 2021 | - | -$2.70 M(-92.0%) | -$16.60 M(+730.0%) |
| Dec 2020 | -$2.00 M(-83.5%) | -$33.90 M(-413.9%) | -$2.00 M(-104.9%) |
| Sept 2020 | - | $10.80 M(+17.4%) | $41.00 M(+85.5%) |
| June 2020 | - | $9.20 M(-22.7%) | $22.10 M(+62.5%) |
| Mar 2020 | - | $11.90 M(+30.8%) | $13.60 M(-212.4%) |
| Dec 2019 | -$12.10 M(-128.9%) | $9.10 M(-212.3%) | -$12.10 M(-33.1%) |
| Sept 2019 | - | -$8.10 M(-1257.1%) | -$18.10 M(-323.5%) |
| June 2019 | - | $700.00 K(-105.1%) | $8.10 M(-69.1%) |
| Mar 2019 | - | -$13.80 M(-545.2%) | $26.20 M(-37.3%) |
| Dec 2018 | $41.80 M | $3.10 M(-82.9%) | $41.80 M(-12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $18.10 M(-3.7%) | $47.60 M(+32.6%) |
| June 2018 | - | $18.80 M(+944.4%) | $35.90 M(+65.4%) |
| Mar 2018 | - | $1.80 M(-79.8%) | $21.70 M(+14.8%) |
| Dec 2017 | $18.90 M(-145.8%) | $8.90 M(+39.1%) | $18.90 M(-112.5%) |
| Sept 2017 | - | $6.40 M(+39.1%) | -$151.80 M(+26.0%) |
| June 2017 | - | $4.60 M(-560.0%) | -$120.50 M(+32.1%) |
| Mar 2017 | - | -$1.00 M(-99.4%) | -$91.20 M(+120.8%) |
| Dec 2016 | -$41.30 M(-41.0%) | -$161.80 M(-529.2%) | -$41.30 M(-110.3%) |
| Sept 2016 | - | $37.70 M(+11.2%) | $399.90 M(-583.6%) |
| June 2016 | - | $33.90 M(-30.7%) | -$82.70 M(+5.4%) |
| Mar 2016 | - | $48.90 M(-82.5%) | -$78.50 M(+12.1%) |
| Dec 2015 | -$70.00 M(-138.3%) | $279.40 M(-162.8%) | -$70.00 M(-76.8%) |
| Sept 2015 | - | -$444.90 M(-1267.7%) | -$301.60 M(-263.7%) |
| June 2015 | - | $38.10 M(-33.6%) | $184.20 M(+15.1%) |
| Mar 2015 | - | $57.40 M(+20.1%) | $160.00 M(-12.4%) |
| Dec 2014 | $182.60 M(-38.5%) | $47.80 M(+16.9%) | $182.60 M(-13.0%) |
| Sept 2014 | - | $40.90 M(+194.2%) | $209.80 M(-18.3%) |
| June 2014 | - | $13.90 M(-82.6%) | $256.70 M(-19.1%) |
| Mar 2014 | - | $80.00 M(+6.7%) | $317.40 M(+6.8%) |
| Dec 2013 | $297.10 M(+3.1%) | $75.00 M(-14.6%) | $297.10 M(+33.8%) |
| Sept 2013 | - | $87.80 M(+17.7%) | $222.10 M(+65.4%) |
| June 2013 | - | $74.60 M(+25.0%) | $134.30 M(+125.0%) |
| Mar 2013 | - | $59.70 M | $59.70 M |
| Dec 2012 | $288.20 M(+8.4%) | - | - |
| Dec 2011 | $265.90 M | - | - |
FAQ
- What is Avanos Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Avanos Medical?
- What is Avanos Medical annual EBITDA year-on-year change?
- What is Avanos Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Avanos Medical?
- What is Avanos Medical quarterly EBITDA year-on-year change?
- What is Avanos Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Avanos Medical?
- What is Avanos Medical TTM EBITDA year-on-year change?
What is Avanos Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of AVNS is $53.20 M
What is the all time high annual EBITDA for Avanos Medical?
Avanos Medical all-time high annual earnings before interest, taxes, depreciation & amortization is $297.10 M
What is Avanos Medical annual EBITDA year-on-year change?
Over the past year, AVNS annual earnings before interest, taxes, depreciation & amortization has changed by -$69.70 M (-56.71%)
What is Avanos Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AVNS is $24.40 M
What is the all time high quarterly EBITDA for Avanos Medical?
Avanos Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is $279.40 M
What is Avanos Medical quarterly EBITDA year-on-year change?
Over the past year, AVNS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$11.30 M (+86.26%)
What is Avanos Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AVNS is $84.70 M
What is the all time high TTM EBITDA for Avanos Medical?
Avanos Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is $399.90 M
What is Avanos Medical TTM EBITDA year-on-year change?
Over the past year, AVNS TTM earnings before interest, taxes, depreciation & amortization has changed by +$24.50 M (+40.70%)